Bavarian Nordic | Sustainability Performance
Bavarian Nordic A/S is involved in the development of immunotherapies and vaccines. The company focuses on addressing unmet medical needs, particularly in infectious diseases and cancer immunotherapy.
1994
Denmark
1,001 - 5,000 employees
Pharmaceuticals
$500M - 1B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4037
Overallⓘ#88
in Denmarkⓘ#94
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Energy consumptionGovernance
TargetsFinancial Data
Business performanceCapital & innovationAnalyst projections
Leading
Controversy level
Powered by illuminem
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
7-10
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.